Drug Approval | February 23, 2023
Moderna and Merck announce investigational personalized cancer vaccine mRNA-4157/V940
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers
AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
Timely screening and accurate detection through precision diagnostics, targeted therapy, risk reducing surgeries, and comprehensive multimodality treatment options have resulted in improving survival rates and quality of life in cancer patients in India
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.
There is also a growing interest in whole generation sequencing (WGS)
Subscribe To Our Newsletter & Stay Updated
